0002125596-26-000003.txt : 20261028 0002125596-26-000003.hdr.sgml : 20261028 20261028102603 ACCESSION NUMBER: 0002125596-26-000003 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20261028 DATE AS OF CHANGE: 20261028 EFFECTIVENESS DATE: 20261028 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BioLattice Ophthalmics, Inc, CENTRAL INDEX KEY: 0002125596 ORGANIZATION NAME: EIN: 320025442 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-578200 FILM NUMBER: 261493560 BUSINESS ADDRESS: STREET 1: 2929 ARCH STREET CITY: PHILADELPHIA STATE: PA ZIP: 19104 BUSINESS PHONE: 267-481-5423 MAIL ADDRESS: STREET 1: 2929 ARCH STREET CITY: PHILADELPHIA STATE: PA ZIP: 19104 D/A 1 primary_doc.xml X0708 D/A LIVE 0002125596 BioLattice Ophthalmics, Inc, 2929 Arch Street Philadelphia PA PENNSYLVANIA 19104 267 481 5423 DELAWARE None None Corporation true 2023 Linda Alunkal 2929 Arch Street Philadelphia PA PENNSYLVANIA 19104 Executive Officer Director Amelia Zellander 2929 Arch Street Philadelphia PA PENNSYLVANIA 19104 Executive Officer Director Gregory Jackson 2929 Arch Street Philadelphia PA PENNSYLVANIA 19104 Director Biotechnology Decline to Disclose 06b true 0002125596-26-000001 2026-03-06 false true false 0 3310000 1825000 1485000 false 7 0 0 0 false BioLattice Ophthalmics, Inc, /s/ Linda Alunkal Linda Alunkal CEO 2026-10-28